Join Now | Sign in

Liver Problems with HIV Medic... Video Transcript

Media Gallery

Videos (22)

	Alcohol and Your Liver play video read transcript
	A Liver.. and a Life: A Transplant Recipient's Story play video read transcript
	The Challenges of Liver Transplantation play video read transcript
	Liver Transplantation play video read transcript
	Treatment of HIV: A Guide For Patients and Doctors play video read transcript
	Once-Daily Medicines for HIV Disease play video read transcript
	Making The Decision To Start HIV Therapy play video read transcript
	HIV Medicines and Cholesterol: Is There a Link? play video read transcript
	Update on Lipodystrophy in HIV play video read transcript
	HIV Therapy: What is HAART? play video read transcript
	Adherence in HIV Disease: How One Person Keeps on Track play video read transcript
	Communicating HIV Treatment Side Effects with Your Doctor play video read transcript
	One Man Faces the Challenges of Cholesterol and HIV play video read transcript
	HIV and Anemia: One Patient's Story play video read transcript
	Lipodystrophy in HIV Disease play video read transcript
	The Grim Reaper: Club Drugs And HIV play video read transcript
	Fast and Easy HIV Testing play video read transcript
	Coping With HIV Drugs: A Personal Story play video read transcript
	HIV and Anemia: An Overlooked Danger play video read transcript
	Sticking to It: An HIV Patient Discusses Adherence play video read transcript
	Central Nervous System Side Effects from HIV Treatment play video read transcript
	Dealing with Wasting in HIV Disease play video read transcript

Marketplace

Liver Problems with HIV Medications

play videoTime: 05:19 minutes

Licensed from

Page: < Back 1 2

Webcast Transcript

BRIAN BOYLE, MD: Medication regimens are evaluated for other potential toxins that may be present. So that the regimen can be put together in as patient-friendly and liver-friendly a way as it can

ANNOUNCER: Other strategies, such as limiting the use of alcohol and avoiding other medicines that may cause damage to the liver, can also be used to lower the risk of liver problems. And sometimes doctors will reduce the dose of HIV medicines for a person who already has liver damage.

EDWIN DeJESUS, MD: Dose reduction, not only liver disease, but in any other chronic medical conditions, are necessary from time to times. Protease inhibitors, sometimes we need to dose-reduce to compensate for that liver deficiency.

ANNOUNCER: Although HIV medicines commonly cause liver problems, many are not serious, allowing people with HIV to benefit from treatment without significant problems.

BRIAN BOYLE, MD: Many patients started on antiretroviral therapy encounter some degree of inflammation of their liver or transaminitis. Most of those are mild to moderate, most resolve on their own over time or stay stable.

EDWIN DeJESUS, MD: Most of the time, we can continue to follow those patients and, as long as that condition does not deteriorate, we can continue their therapy effectively and safely.